Intracellular accumulation of incompletely processed transforming growth factor-alpha polypeptides in ground glass hepatocytes of chronic hepatitis B virus infection

Journal of Hepatology

Volumn 24, Issue 5, 1996, Pages 547-554

  Schirmacher, Peter ^a,b   Schauß, Dagmar ^a   Dienes, Hans Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Growth factor; Hepatitis; Hepatitis B virus; Hepatocytes; Transforming growth factor alpha

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CELL; PRIORITY JOURNAL;

EID: 17344387743     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80139-5     Document Type: Article

References (43)

1. Derynck R. Transforming Growth Factor alpha: structure and biological activities. J Cell Biochem 1986; 32: 293-304.
2. Lyons RM, Moses HL. Transforming factors and the regulation of cell proliferation. Eur J Biochem 1990; 187: 467-73.
3. Bringman TS, Lindquist PB, Derynck R. Different transforming growth factor-species are derived from a glycosylated and palmytoylated transmembrane precursor. Cell 1987; 48: 429-40.
4. Teixido J, Gilmore R, Lee DC, Massague J. Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-alpha. Nature 1987; 326: 883-5.
5. Bosenberg MW, Pandiella A, Massague J. The cytoplasmic carboxy-terminal aminoacid specifies cleavage of membrane TGF alpha into soluble growth factor. Cell 1992; 71: 1157-65.
6. Todaro GJ, DeLarco JE, Cohen S. Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature 1976; 264: 26-31.
7. Massague J. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem 1983; 258: 13614-20.
8. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 313: 745-7.
9. Smith JJ, Derynck R, Korc M. Production of transforming growth factor-α in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 1987; 84: 7567-70.
10. Lee DC, Rose TM, Webb NR, Todaro GJ. Cloning and sequence analysis of a cDNA for rat transforming growth factor α. Nature 1985; 313: 489-91.
11. Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR. Production and autoinduction of transforming growth factor-alpha in human keratinocytes. Nature 1987; 328: 817-20.
12. Wilcox JN, Derynck R. Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain. J Neurosci 1988; 8: 1901-4.
13. Lee DC, Rochford R, Todaro GJ, Villareal LP. Developmental expression of rat transforming growth factor α mRNA. Mol Cell Biol 1985; 5: 3644-6.
14. Wilcox JN, Derynck R. Developmental expression of transforming growth factor alpha and beta in mouse fetus. Mol Cell Biol 1988; 8: 3415-22.
15. Schreiber A, Winkler HJ, Derynck R. Transforming growth factor α is a more potent angiogenic mediator than epidermal growth factor. Science 1986; 323: 2228-32.
16. Schultz GS, Rotatori DS, Clark W. EGF and TGF in wound healing and repair. J Cell Biochem 1991; 45: 346-52.
17. Mead JE, Fausto N. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989; 6: 1558-62.
18. Derynck R, Goeddel DV, Ullrich A, Gutterman JK, Williams RD, Bringman TS, Berger NM. Synthesis of messenger RNAs for transforming growth factor alpha and the epidermal growth factor by human tumours. Cancer Res 1987; 47: 707-12.
19. Yen YC, Tsai JF, Chuang LY, Yeh MW, Tsai JM, Florine DL, Tam JP. Elevation of transforming growth factor α and its relationship with the epidermal growth factor and α fetoprotein levels in patients with hepatocellular carcinoma. Cancer Res 1987; 47: 896-901.
20. Raymond VW, Lee DC, Grisham JW, Earp MS. Regulation of transforming growth factor messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester. Cancer Res 1989; 49: 3608-12.
21. Jhappan C, Stahle C, Markins RN, Fausto N, Smith GM, Merlino GT. TGF α overexpression induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61: 1137-46.
22. Sandgren EP, Luettecke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993; 13: 320-30.
23. Schirmacher P, Rogler CE, Dienes HP. Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Arch B (Cell Pathol) 1993; 63: 71-89.
24. Sorvillo JM, McCormack ES, Yanez L, Valenzuela D, Reynolds FH. Preparation and characterization of monoclonal antibodies specific for human transforming growth factor-alpha. Oncogene 1990; 5: 377-86.
25. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 1984; 52: 396-402.
26. Gerber MA, Hadziyannis SJ, Vissoulis C, Schaffner F, Paronetto F, Popper H. Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol 1974; 75: 489-502.
27. Rogler CE, Hino O, Yang D, Shafritz DA. Viral DNA integration, chromosome aberration, and growth factor activation in hepatocellular carcinomas of hepadna virus carriers. In: Bannasch P, Keppler D, Weber G, eds. Liver Cell Carcinoma. Dordrecht: Kluwer Academic Publ, 1989: 93-106.
28. Brenner DA, Koch KS, Leffert HL. Transforming growth factor alpha stimulates protooncogene c-jun expression and a mitogenic program in primary cultures of adult rat hepatocytes. DNA 1989; 8: 279-85.
29. Hoffmann B, Paul D. Basic fibroblast growth factor and transforming growth factor-α are hepatotrophic mitogens in vitro. J Cell Physiol 1990; 142: 149-54.
30. Liu C, Tsao M-S, Grisham JW. Transforming growth factors produced by normal and transformed rat liver epithelial cells in culture. Cancer Res 1988; 48: 850-5.
31. Chisari FV, Filippi P, Burns J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA 1987; 84: 6909-13.
32. Hadziyannis SJ, Gerber MA, Vissoulis C, Popper H. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol 1973; 96: 327-30.
33. Dienes HP, Gerlich WH, Wörsdörfer M, Gerken G, Bianchi L, Hess G, Meyer zum Büschenfelde, KH. Hepatic expression pattern of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. Gastroenterology 1990; 98: 1017-23.
34. Persing DH, Varmus HE, Ganem D. Inhibition of secretion of hepatitis B virus surface antigen by a related presurface polypeptide. Science 1986; 234: 1388-91.
35. Standring DN, Ou J-H, Rutter WJ. Assembly of viral particles in xenopus oocytes: pre-surface antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci USA 1986; 83: 9338-42.
36. Cheng K-C, Smith GL, Moss B. Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol 1986; 60: 337-44.
37. Ganem D, Varmus HE. The molecular biology of hepatitis B viruses. Annu Rev Biochem 1987; 56: 651-93.
38. Pfaff E, Klinkert M-Q, Theilmann L, Schaller H. Characterization of large surface proteins of hepatitis B virus by antibodies to preS-S encoded aminoacids. Virology 1986; 148: 15-22.
39. Eble B, Lingappa V, Ganem D. Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. Mol Cell Biol 1986; 6: 1454-63.
40. Prange R, Streeck RE. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J 1995; 14: 247-56.
41. Castilla A, Prieto J, Fausto N. Transforming growth factor betal and alpha in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991; 324: 933-40.
42. Hsia CC, Axiotis CA, DiBisceglie AM, Tabor E. Transforming growth factor-alpha in hepatocellular carcinoma and co-expression with hepatitis B surface antigen in adjacent liver. Cancer 1992; 70: 1049-56.
43. Chisari FR, Filippi P, McLachlan A, Milich DR, Riggs M, Lee S, Palmiter RD, Pinkert CA, Brinster RL. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol 1986; 60: 880-7.